Status: current, Defined. Date: 30-Jun 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1633011000168116 | doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL injection, 10 x 10 mL vials (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1633021000168111 | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 x 10 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 x 10 mL vials | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 x 10 mL vials | has MPUU | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Caelyx (doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL) injection, 10 x 10 mL vials (trade product pack) | Is a | True | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 x 10 mL vials | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR